Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.

Molecular psychiatry·2017
Same author

Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis.

Leukemia·2013
Same author

Epigenetic memory in induced pluripotent stem cells.

Nature·2010
Same author

Uber infektiöse Substrukturen aus Bakteriophagen. VI. A simple method for separating the replicative form from single-stranded phiX174 DNA.

Journal of molecular biology·2009
Same author

Uber infektiöse Substrukturen aus Escherichia coli Bakteriophagen. VIII. On the tertiary structure and biological properties of phiX174 replicative form.

Journal of molecular biology·2009
Same author

Stem cells, pluripotency and nuclear reprogramming.

Journal of thrombosis and haemostasis : JTH·2009

Related Experiment Video

Updated: Jun 5, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

Gene targeting in human pluripotent cells.

D Hockemeyer1, R Jaenisch

  • 1Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.

Cold Spring Harbor Symposia on Quantitative Biology
|January 7, 2011
PubMed
Summary

Efficient gene targeting in human pluripotent stem cells is crucial for biomedical research. Custom-engineered zinc-finger nucleases offer a promising solution for robust genetic modification, advancing disease modeling and therapeutics.

Area of Science:

  • Stem cell biology
  • Genetic engineering
  • Biomedical research

Background:

  • Mouse embryonic stem cells (mESCs) are vital for biomedical research due to their pluripotency and established gene targeting methods.
  • Human pluripotent stem cells (hPSCs) hold immense potential for disease modeling and therapeutics, but genetic manipulation is challenging.
  • Robust genetic tools are needed for hPSCs, mirroring the efficiency seen in mESCs.

Purpose of the Study:

  • To review strategies for specific genetic modifications in human pluripotent cells.
  • To highlight the application of custom-engineered zinc-finger nucleases (ZFNs) for gene targeting in hPSCs.

Main Methods:

  • Discussion of various gene targeting strategies employed in human pluripotent cells.
  • Focus on the utilization of custom-engineered zinc-finger nucleases (ZFNs).

More Related Videos

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
12:13

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

Published on: August 23, 2014

Related Experiment Videos

Last Updated: Jun 5, 2026

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
09:03

Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing

Published on: May 10, 2020

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells
12:13

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

Published on: August 23, 2014

Main Results:

  • Gene targeting in hPSCs is historically more difficult, time-consuming, and less efficient than in mESCs.
  • Custom-engineered ZFNs show promise as a robust tool for efficient genetic manipulation of hPSCs.

Conclusions:

  • Developing efficient gene targeting methods for hPSCs is essential to unlock their full potential.
  • Custom-engineered ZFNs represent a significant advancement for genetic manipulation in human pluripotent stem cells, paving the way for novel disease models and therapies.